Kurreck Jens
Institute of Industrial Genetics, University of Stuttgart, Allmandring 31, 70569 Stuttgart, Germany.
Angew Chem Int Ed Engl. 2009;48(8):1378-98. doi: 10.1002/anie.200802092.
An efficient mechanism for the sequence-specific inhibition of gene expression is RNA interference. In this process, double-stranded RNA molecules induce cleavage of a selected target RNA (see picture). This technique has in recent years developed into a standard method of molecular biology. Successful applications in animal models have already led to the initiation of RNAi-based clinical trials as a new therapeutic option.Only ten years ago Andrew Fire and Craig Mello were able to show that double-stranded RNA molecules could inhibit the expression of homologous genes in eukaryotes. This process, termed RNA interference, has developed into a standard method of molecular biology. This Review provides an overview of the molecular processes involved, with a particular focus on the posttranscriptional inhibition of gene expression in mammalian cells, the possible applications in research, and the results of the first clinical studies.
一种用于序列特异性抑制基因表达的有效机制是RNA干扰。在这个过程中,双链RNA分子诱导选定的靶RNA发生切割(见图)。近年来,这项技术已发展成为分子生物学的标准方法。在动物模型中的成功应用已经促使基于RNA干扰的临床试验作为一种新的治疗选择得以启动。仅仅在十年前,安德鲁·法尔和克雷格·梅洛才得以证明双链RNA分子能够抑制真核生物中同源基因的表达。这个被称为RNA干扰的过程,已发展成为分子生物学的标准方法。本综述概述了其中涉及的分子过程,特别关注哺乳动物细胞中基因表达的转录后抑制、在研究中的可能应用以及首批临床研究的结果。